Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study von Järnerot, Gunnar, Hertervig, Erik, Friis-Liby, Ingalill, Blomquist, Lars, Karlén, Per, Grännö, Christer, Vilien, Mogens, Ström, Magnus, Danielsson, Åke, Verbaan, Hans, Hellström, Per M., Magnuson, Anders, Curman, Bengt

Volltext

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study von Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Vyron, Udumyan, Ruzan, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas

Volltext

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study von Visuri, Isabella, Eriksson, Carl, Karlqvist, Sara, Lykiardopoulos, Byron, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas

Volltext

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease von Bergqvist, Viktoria, Kadivar, Mohammad, Molin, Daniel, Angelison, Leif, Hammarlund, Per, Olin, Marie, Torp, Jörgen, Grip, Olof, Nilson, Stefan, Hertervig, Erik, Lillienau, Jan, Marsal, Jan

Volltext

Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice von Chen, Ying, Zhang, Ping, Xu, Shu-Chang, Yang, Liping, Voss, Ulrikke, Ekblad, Eva, Wu, Yunjin, Min, Yalan, Hertervig, Erik, Nilsson, Åke, Duan, Rui-Dong

Volltext

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis von Bergqvist, Viktoria, Hertervig, Erik, Gedeon, Peter, Kopljar, Marija, Griph, Håkan, Kinhult, Sara, Carneiro, Ana, Marsal, Jan

Volltext

The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease von Bolin, Kristian, Hertervig, Erik, Louis, Edouard

Volltext

Purification, localization, and expression of human intestinal alkaline sphingomyelinase von Duan, Rui-Dong, Cheng, Yajun, Hansen, Gert, Hertervig, Erik, Liu, Jian-Jun, Syk, Ingvar, Sjostrom, Hans, Nilsson, Ake

Volltext

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease von Ungaro, Ryan C., Yzet, Clara, Bossuyt, Peter, Baert, Filip J., Vanasek, Thomas, D’Haens, Geert R., Joustra, Vincent Wilhelmus, Panaccione, Remo, Novacek, Gottfried, Reinisch, Walter, Armuzzi, Alessandro, Golovchenko, Oleksandr, Prymak, Olga, Goldis, Adrian, Travis, Simon P., Hébuterne, Xavier, Ferrante, Marc, Rogler, Gerhard, Fumery, Mathurin, Danese, Silvio, Rydzewska, Grazyna, Pariente, Benjamin, Hertervig, Erik, Stanciu, Carol, Serrero, Melanie, Diculescu, Mircea, Peyrin-Biroulet, Laurent, Laharie, David, Wright, John P., Gomollón, Fernando, Gubonina, Irina, Schreiber, Stefan, Motoya, Satoshi, Hellström, Per M., Halfvarson, Jonas, Butler, James W., Petersson, Joel, Petralia, Francesca, Colombel, Jean-Frederic

Volltext

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study von Gustavsson, A., Järnerot, G., Hertervig, E., Friis‐Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Verbaan, H., Hellström, P. M., Magnuson, A., Halfvarson, J., Tysk, C.

Volltext

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial von Münch, Andreas, Bohr, Johan, Miehlke, Stephan, Benoni, Cecilia, Olesen, Martin, Öst, Åke, Strandberg, Lars, Hellström, Per M, Hertervig, Erik, Armerding, Peter, Stehlik, Jiri, Lindberg, Greger, Björk, Jan, Lapidus, Annika, Löfberg, Robert, Bonderup, Ole, Avnström, Sören, Rössle, Martin, Dilger, Karin, Mueller, Ralph, Greinwald, Roland, Tysk, Curt, Ström, Magnus

Volltext

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG von Eriksson, Carl, Visuri, Isabella, Vigren, Lina, Nilsson, Linda, Kärnell, Anders, Hjortswang, Henrik, Bergemalm, Daniel, Almer, Sven, Hertervig, Erik, Karlén, Per, Strid, Hans, Halfvarson, Jonas

Volltext

Infliximab as rescue therapy in hospitalised patients with steroid‐refractory acute ulcerative colitis: a long‐term follow‐up of 211 Swedish patients von Sjöberg, M., Magnuson, A., Björk, J., Benoni, C., Almer, S., Friis‐Liby, I., Hertervig, E., Olsson, M., Karlén, P., Eriksson, A., Midhagen, G., Carlson, M., Lapidus, A., Halfvarson, J., Tysk, C.

Volltext

Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study von Angelison, Leif, Almer, Sven, Davidsdottir, Loa, Hammarlund, Per, Lindgren, Stefan, Hindorf, Ulf, Marsal, Jan, Hertervig, Erik

Volltext

887: WITHDRAWAL OF INFLIXIMAB OR ANTI-METABOLITE THERAPY IN CROHN'S DISEASE PATIENTS IN SUSTAINED REMISSION ON COMBINATION THERAPY: A RANDOMIZED UNBLINDED CONTROLLED TRIAL (SPARE) von Louis, Edouard, Resche-Rigon, Matthieu, Laharie, David, Satsangi, Jack J., Ding, Nik S., Siegmund, Britta, D'Haens, Geert R., Picon, Laurence, Bossuyt, Peter, Vuitton, Lucine, Irving, Peter M., Bouhnik, Yoram, Viennot, Stephanie, Lamb, Christopher A., Pollock, Richard C., Baert, Filip J., Nachury, Maria, Fumery, Mathurin, Gilletta, Cyrielle, Colombel, Jean Frederic, Hertervig, Erik

Volltext

Mo1886 REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY von Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Byron, Udumyan, Ruzan, Karlén, Per, Grip, Olof, Soderman, Charlotte, Almer, Sven, Hertervig, Erik, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Daniel, Bergemalm, Hjortswang, Henrik, Halfvarson, Jonas

Volltext

Alkaline sphingomyelinase (NPP7) promotes cholesterol absorption by affecting sphingomyelin levels in the gut: A study with NPP7 knockout mice von Zhang, Ping, Chen, Ying, Cheng, Yajun, Hertervig, Erik, Ohlsson, Lena, Nilsson, Ake, Duan, Rui-Dong

Volltext

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial von Danese, Silvio, Vermeire, Severine, D'Haens, Geert, Panés, Julian, Dignass, Axel, Magro, Fernando, Nazar, Maciej, Le Bars, Manuela, Lahaye, Marjolein, Ni, Lioudmila, Bravata, Ivana, Lavie, Frederic, Daperno, Marco, Lukáš, Milan, Armuzzi, Alessandro, Löwenberg, Mark, Gaya, Daniel R, Peyrin-Biroulet, Laurent, Rocca, Rodolfo, Lopes, Susana, Caprioli, Flavio, Ardizzone, Sandro, Echarri Piudo, Ana, Gionchetti, Paolo, Roblin, Xavier, Seidler, Ursula, Andersson, David, Patel, Kamal, Desreumaux, Pierre, Saibeni, Simone, From, Gustav, Fedurco, Miroslav, Gregus, Milos, Bouhnik, Yoram, Luegering, Andreas, Cosintino, Rocco, Bunganic, Ivan, Ramos, Jaime, Aguas Peris, Mariam, Dewit, Olivier, Principi, Mariabeatrice, Wesley, Emma, Lago, Paula, Nancey, Stephane, Martín Arranz, María Dolores, Hindryckx, Pieter, Orlando, Ambrogio, Geccherle, Andrea, Annunziata, Maria Laura, Hayee, Bu'hussain, Balaz, Jozef, Portela, Francisco, Gilletta, Cyrielle, Kucharzik, Torsten, Mínguez, Miguel, Gisbert, Javier Pérez, Casbas, Ana Gutiérrez, Louis, Edouard, Parkes, Gareth, Cummings, Fraser, Jharap, Bindia, Kjeldsen, Jens, Correia, Luís, Ministro, Paula, Ebert, Matthias, Hertervig, Erik, Staessen, Dirk, Dutré, Joris, Colard, Arnaud, Morrison, Graham, Glerup, Henning, Dahlerup, Jens Frederik, Wolfhagen, Frank, Batovsky, Marian, Molnar, Martin, Kadleckova, Barbora, Caldeira, Paulo, Laharie, David, Hebuterne, Xavier, Bonaz, Bruno, Allez, Matthieu, Fischer, Andreas, Hinojosa Del Val, Joaquín Ernesto, Ciria, Miriam Mañosa, Herrera Justiniano, Jose Manuel, Soderman, Charlotte, Chandy, Rajiv, Mowat, Craig, Irving, Peter, Fallingborg, Jan, Matous, Jan, Douda, Tomas, Altwegg, Romain, Benitez, Jose Manuel, Arroyo Villarino, María Teresa, Capón, Jordi Guardiola, Vicenc, Daniel Ginard, Dewint, Pieter, Almer, Sven, Kindt, Sebastien

Volltext

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled... von Louis, Edouard, Resche-Rigon, Matthieu, Laharie, David, Satsangi, Jack, Ding, Nik, Siegmund, Britta, D'Haens, Geert, Picon, Laurence, Bossuyt, Peter, Vuitton, Lucine, Irving, Peter, Viennot, Stephanie, Lamb, Christopher A, Pollok, Richard, Baert, Filip, Nachury, Maria, Fumery, Mathurin, Gilletta, Cyrielle, Almer, Sven, Ben-Horin, Shomron, Bouhnik, Yoram, Colombel, Jean-Frederic, Hertervig, Erik, Andrews, Jane, Sparrow, Miles, Leong, Rupert, Connor, Susan, Radforth-Smith, Graham, De Cruz, Peter, Preiss, Jan, Stallmach, Andrea, Liceni, Thomas, Grip, Olaf, Halfvarson, Jonas, Durai, Dharmaraj, Cummings, Fraser, Seilinger, Christian, Parkes, Miles, Lindsay, James, Lambrecht, Guy, Van Hootegem, Philippe, Rahier, Jean-François, Dewitte, Marie, Hebuterne, Xavier, Chanteloup, Elise, Altwegg, Romain, Nancey, Stephane, Bouguen, Guillaume, Pineton de Chambrun, Guillaume, Poullenot, Floriant, Roblin, Xavier

Volltext

Mo1894 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Pa... von Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Vyron, Karlén, Per, Grip, Olof, Soderman, Charlotte, Almer, Sven, Hertervig, Erik, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Bergemalm, Daniel, Udumyan, Ruzan, Hjortswang, Henrik, Halfvarson, Jonas

Volltext